Pfizer's new RSV vaccine may trigger Guillain-Barre syndrome
1 Mins read
Reading Time: < 1 minute Pfizer‘s new RSV vaccine for older adults may trigger the potentially deadly Guillain-Barre syndrome, the Food and Drug Administration (FDA) has warned. Read More